DGS Capital Management, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1900110
JERSEY CITY, NJ
Position in TAK
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$427,923
+$207,013 QoQ
Shares Held
23,106
+63.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $2,551,701 across 7 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
52,937 | $733,177 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,034 | $613,141 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
23,106 | $427,923 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,945 | $329,663 | |
| 5 | SIGA |
Siga Technologies Inc
|
42,434 | $227,021 | |
| 6 | VTRS |
Viatris Inc
|
12,475 | $168,537 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
14,883 | $52,239 |
All Filings in TAK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $427,923 | 23,106 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $220,910 | 14,170 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $251,354 | 17,169 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $266,128 | 17,214 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $253,384 | 17,040 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $148,023 | 11,180 | Shares | Sole | 2025-01-21 | |
| No filing history on record for this holder in this stock. | ||||||